Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Aratana Therapeutics Inc (NASDAQ:PETX)

17.64
Delayed Data
As of Aug 28
 +0.09 / +0.51%
Today’s Change
9.20
Today|||52-Week Range
20.63
-1.01%
Year-to-Date

Stock Price Forecast

The 7 analysts offering 12-month price forecasts for Aratana Therapeutics Inc have a median target of 28.00, with a high estimate of 38.00 and a low estimate of 23.00. The median estimate represents a +58.73% increase from the last price of 17.64.

Analyst Recommendations

The current consensus among 8 polled investment analysts is to Buy stock in Aratana Therapeutics Inc. This rating has held steady since August, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.38
Sales
$296.8K
Reporting Date
Nov 11

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -64.13%
 
 
 
 
 
 
Growthannually -5.29%
 
 
 
 
 

Sales

Growthquarterly 29.04%
 
 
 
 
 
 
Growthannually 35.30%
 
 
 
 
 
Key to the earnings and sales forecast charts.